Kidney Disease
House representative: Despite COVID-19, Congress maintains focus on advancing kidney care
At the virtual Innovations in Dialysis: Expediting Advances Symposium, U.S. Rep. Suzan DelBene, D-Wash., assured the audience that Congress continues its efforts to improve care for patients with kidney disease.
Dapagliflozin cuts renal, CV events in CKD, regardless of diabetes status
In the DAPA-CKD trial, treatment with the SGLT2 inhibitor dapagliflozin reduced risk for worsening renal function and death due to CVD or renal disease in patients with chronic kidney disease, both with and without type 2 diabetes.
ASN, NKF form joint task force to reassess inclusion of race in kidney disease diagnoses
The American Society of Nephrology has partnered with the National Kidney Foundation to examine how the inclusion of race in eGFR estimations may influence kidney disease diagnoses.
Interpretation of urine sediment tests varies among nephrologists
Researchers observed substantial variability among nephrologists in their interpretations of findings from urine sediment examinations during kidney disease evaluations.
NKF releases 2020 clinical practice guideline for nutrition in CKD
In collaboration with the Academy of Nutrition and Dietetics, the National Kidney Foundation has released the 2020 Kidney Disease Outcome Quality Initiative Clinical Practice Guideline for Nutrition in Chronic Kidney Disease.
Primary care, education must be part of approach to CKD strategy
Despite major advances in medical treatment related to other disease processes, kidney disease still remains in the top seven chronic diseases in America.
Both central, general adiposity lead to higher risks for kidney disease
Risks for kidney disease rise with increasing adiposity regardless of fat distribution and presence of diabetes, according to a study published in the International Journal of Obesity.
Dapagliflozin slows renal disease, reduces death risk regardless of diabetes status
The SGLT2 inhibitor dapagliflozin was linked to significant reductions in worsening renal function and renal or cardiovascular death in adults with chronic kidney disease irrespective of type 2 diabetes, according to a press release.
Study finds ‘concerning’ lack of trials on exercise in early stages of kidney disease
A study review showed exercise has a beneficial impact on patients with varying stages of kidney disease but, because most of the studies focused on those already on dialysis, the researchers urge physical activity be considered earlier.
HF hospitalization in adult congenital heart disease confers 4-year elevated death risk
Among adults with congenital heart disease hospitalized for HF, mortality risk remained high for up to 4 years after hospital discharge, according to a study published in Circulation: Heart Failure.